ZA975637B - Method for the treatment of emesis. - Google Patents

Method for the treatment of emesis.

Info

Publication number
ZA975637B
ZA975637B ZA9705637A ZA975637A ZA975637B ZA 975637 B ZA975637 B ZA 975637B ZA 9705637 A ZA9705637 A ZA 9705637A ZA 975637 A ZA975637 A ZA 975637A ZA 975637 B ZA975637 B ZA 975637B
Authority
ZA
South Africa
Prior art keywords
emesis
treatment
Prior art date
Application number
ZA9705637A
Other languages
English (en)
Inventor
David Christopher Horwell
John Hughes
Martyn Clive Pritchard
Lakhbir Singh
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA975637B publication Critical patent/ZA975637B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9705637A 1996-06-26 1997-06-25 Method for the treatment of emesis. ZA975637B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2103096P 1996-06-26 1996-06-26

Publications (1)

Publication Number Publication Date
ZA975637B true ZA975637B (en) 1998-01-23

Family

ID=21801924

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9705637A ZA975637B (en) 1996-06-26 1997-06-25 Method for the treatment of emesis.

Country Status (9)

Country Link
US (1) US5998435A (de)
EP (1) EP0912173A1 (de)
JP (1) JP2000514047A (de)
AU (1) AU714542B2 (de)
CA (1) CA2255651A1 (de)
CO (1) CO4950543A1 (de)
NZ (1) NZ333062A (de)
WO (1) WO1997049393A1 (de)
ZA (1) ZA975637B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003167A1 (en) 1996-07-24 1998-01-29 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain
CA2323047C (en) * 1998-04-15 2005-03-15 Warner-Lambert Company Prodrugs of benzofuranylmethyl carbamate nk, antagonists
US7254167B2 (en) * 1998-10-30 2007-08-07 Broadcom Corporation Constellation-multiplexed transmitter and receiver
UA76810C2 (uk) * 2001-12-10 2006-09-15 Мерк Енд Ко., Інк. Фармацевтична композиція антагоніста рецептора тахікініну у формі наночастинок
JP2010516731A (ja) 2007-01-24 2010-05-20 グラクソ グループ リミテッド ２−メトキシ−５−（５−トリフルオロメチル−テトラゾール−１−イル）−ベンジル］−（２ｓ−フェニル−ピペリジン−３ｓ−イル）−アミンを含む医薬組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0916346A3 (de) * 1991-09-20 2000-12-06 Glaxo Group Limited NK-1 Rezeptor Antagonisten und 5HT3 Rezeptor Antagonisten zur Behandlung von Emesis
EP1000930A3 (de) * 1992-08-13 2003-10-29 Warner-Lambert Company Tachykinin Antagoniste
GB9305718D0 (en) * 1993-03-19 1993-05-05 Glaxo Group Ltd Medicaments
GB9317987D0 (en) * 1993-08-26 1993-10-13 Glaxo Group Ltd Chemical compounds
IL111002A (en) * 1993-09-22 1998-09-24 Glaxo Group Ltd History of piperidine, their preparation and the pharmaceutical preparations containing them
DK0764163T3 (da) * 1994-06-06 2002-02-04 Warner Lambert Co Tachykinin (NK1) receptor-antagonister

Also Published As

Publication number Publication date
WO1997049393A1 (en) 1997-12-31
NZ333062A (en) 2000-06-23
CO4950543A1 (es) 2000-09-01
AU3571897A (en) 1998-01-14
AU714542B2 (en) 2000-01-06
EP0912173A1 (de) 1999-05-06
CA2255651A1 (en) 1997-12-31
US5998435A (en) 1999-12-07
JP2000514047A (ja) 2000-10-24

Similar Documents

Publication Publication Date Title
AU1527897A (en) Method for treating the prostate
ZA977948B (en) Process for the control of weeds.
ZA971038B (en) Process for the partial oxidation of alkanes.
HK1027280A1 (en) Plant extracts for the treatment of increased boneresorption.
ZA97631B (en) Migraine treatment.
ZA9710322B (en) Process for the preparation of benzyl-ethers.
HK1010220A1 (en) Method for surface treatment.
ZA973707B (en) Method for treating inflammation.
ZA976824B (en) Chemical process.
ZA986363B (en) Novel method of treatment.
ZA971576B (en) Process for obtaining isophorone.
EP0626413A3 (de) Verfahren zur Herstellung von Diorganopolysiloxanen.
ZA985237B (en) Novel method of treatment.
GB9605828D0 (en) Treatment method
ZA973847B (en) Chemical process.
ZA971263B (en) Diagnostic method.
ZA978640B (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.
EP0672457A3 (de) Verfahren zur rückstandsfreien Abfallbehandlung.
GR950100091A (en) Method for the treatment of plants.
ZA972061B (en) New method.
EP0669361A3 (de) Verfahren zur Herstellung von Polyheterosiloxanen.
ZA986364B (en) Novel method of treatment.
ZA973400B (en) Method for the manufacture of brushes.
ZA975637B (en) Method for the treatment of emesis.
ZA986365B (en) Novel method of treatment.